| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |